Page last updated: 2024-11-03

ranitidine and Acute Confusional Senile Dementia

ranitidine has been researched along with Acute Confusional Senile Dementia in 1 studies

Research Excerpts

ExcerptRelevanceReference
"Alzheimer's disease is a progressive brain disorder with characteristic symptoms and several pathological hallmarks."1.622-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease. ( Andrys, R; Capek, J; Handl, J; Hrabinova, M; Janockova, J; Kobrlova, T; Korabecny, J; Marco-Contelles, JL; Mezeiova, E; Micankova, P; Muckova, L; Nepovimova, E; Pejchal, J; Rousar, T; Simunkova, M; Soukup, O; Valko, M, 2021)

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's0 (0.00)24.3611
2020's1 (100.00)2.80

Authors

AuthorsStudies
Mezeiova, E1
Janockova, J1
Andrys, R1
Soukup, O1
Kobrlova, T1
Muckova, L1
Pejchal, J1
Simunkova, M1
Handl, J1
Micankova, P1
Capek, J1
Rousar, T1
Hrabinova, M1
Nepovimova, E1
Marco-Contelles, JL1
Valko, M1
Korabecny, J1

Other Studies

1 other study available for ranitidine and Acute Confusional Senile Dementia

ArticleYear
2-Propargylamino-naphthoquinone derivatives as multipotent agents for the treatment of Alzheimer's disease.
    European journal of medicinal chemistry, 2021, Feb-05, Volume: 211

    Topics: Alzheimer Disease; Drug Design; Humans; Naphthoquinones; Structure-Activity Relationship

2021